This distinctive honor was presented to Johns Creek at the 2023 Georgia Life Sciences Summit organized by Georgia Bio, a non-profit, membership-based organization that promotes the interests and growth of the life sciences industry in Georgia.
Georgia Bio launched the BioReady® Community program in Georgia with the support from the non-profit’s partners at MassBio, a global life sciences and healthcare organization dedicated to advancing Massachusetts’ position in the life sciences.
With a goal of helping local communities connect with leading life sciences industry representatives, Georgia Bio replicated the MassBio rating system program to determine a municipality’s readiness to host biotechnology facilities based on the community’s zoning practices and infrastructure capacity.
As the state’s largest and most influential life sciences advocacy and business leadership organization, Georgia Bio works to improve access to innovative technologies and grow Georgia’s life sciences economy.
The BioReady® rating system rates communities in three tiers from Bronze to Silver to Gold. Through these BioReady® ratings, Georgia Bio seeks to provide cities and towns a platform to effectively tell their stories to the biotechnology industry, ultimately helping real estate developers and biotechnology companies find the most favorable destinations to locate.
“The life sciences sector in Georgia continues to grow at a rapid pace, which means the need for bioready sites is continually increasing,” said Maria Thacker-Goethe, President and CEO of Georgia Bio. “The BioReady® program allows municipalities to showcase biotech-zoned science parks, streamline permitting, build a robust infrastructure, and identify biotech-friendly sites more effectively.”
Learn more on the Georgia Bio’s BioReady Communities website.
About Georgia Bio
Georgia Bio (GaBio) is the state’s most impactful life sciences membership organization, advocating for the sector and its diverse innovation pipeline. For more than 30 years, GaBio has served its members by supporting companies of all sizes, from early-stage innovators and startups to established industry leaders in the fields of biotechnology, pharmaceuticals, and medical technology. GaBio also works closely with universities, academic and research institutions, the investment community, and other critical partners that promote this vibrant sector. GaBio works to shape public policy, improve access to breakthrough technologies, educate lawmakers, provide member programs, build workforce, and advance equity within our ecosystem by championing innovative solutions for some of the most pressing challenges of our times. For more information, visit www.gabio.org.